ellipticine has been researched along with camptothecin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, HJ; Kim, JS; Kim, YS; Lee, EJ; Lee, SK; Park, HJ; Ryu, CK; Suh, ME; Yi, YJ | 1 |
| Choo, HY; Kim, JS; Lee, HJ; Lee, IK; Lee, SK; Park, HJ; Rhee, HK; Ryu, CK; Suh, ME | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Cho, WJ; Kang, BY; Kwon, Y; Le, QM; Lee, ES; Lee, SK; My Van, HT; Youl Lee, K | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Cho, WJ; Khadka, DB | 1 |
| Cho, SH; Cho, WJ; Khadka, DB; Kwon, Y; Le, QM; Le, TN; Lee, ES; Lee, KT; Van, HT; Yang, SH | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Cao, HT; Chau, MV; Cho, WJ; Jin, Y; Khadka, DB; Kwon, Y; Le, TN; Nguyen, HT; Shin, S; Tran, GH; Van, HT; Zhao, C | 1 |
| Bist, G; Kadayat, TM; Kwon, Y; Lee, ES; Lee, HJ; Park, S; Shrestha, A; Thapa Magar, TB | 1 |
| Barresi, E; Da Settimo, F; Dalla Via, L; García-Argáez, AN; Hyeraci, M; La Pietra, V; Marinelli, L; Marini, AM; Milite, C; Novellino, E; Robello, M; Salerno, S; Simorini, F; Taliani, S | 1 |
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
| Sumner, AT | 1 |
| Hsu, MT; Wong, ML | 1 |
| Shin, CG; Snapka, RM | 1 |
| Kawanishi, M | 1 |
| Frei, H; Würgler, FE | 1 |
| Falaschi, A; Ochem, A; Phan, TN; Tuteja, N; Tuteja, R | 1 |
| Phan, TN; Tuteja, N | 1 |
| Deslandes, E; Gauduchon, P; Godard, T; Poul, JM; Sichel, F | 1 |
| Dudgeon, DD; Giuliano, KA; Johnston, PA; Lazo, JS; Shinde, SN; Shun, TY; Strock, CJ; Taylor, DL | 1 |
| Pham, XH; Tran, NQ; Tuteja, N; Tuteja, R | 1 |
2 review(s) available for ellipticine and camptothecin
| Article | Year |
|---|---|
3-Arylisoquinolines as novel topoisomerase I inhibitors.
Topics: Antineoplastic Agents; DNA Topoisomerases, Type I; Isoquinolines; Topoisomerase I Inhibitors | 2011 |
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
20 other study(ies) available for ellipticine and camptothecin
| Article | Year |
|---|---|
6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA Topoisomerases; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Quinazolines; Structure-Activity Relationship; Topoisomerase Inhibitors | 2004 |
Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
Topics: Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; DNA; Drug Screening Assays, Antitumor; Drug Stability; Enzyme Inhibitors; Humans; Isoquinolines; Molecular Structure; Permeability; Phenazines; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; DNA; DNA Topoisomerases, Type I; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Isoquinolines; Models, Chemical; Models, Molecular; Topoisomerase Inhibitors; X-Rays | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors.
Topics: Binding Sites; Cell Line, Tumor; Computer Simulation; DNA Topoisomerases, Type I; Drug Design; Humans; Isoquinolines; Piperazines; Quantitative Structure-Activity Relationship; Topoisomerase I Inhibitors | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.
Topics: Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Molecular Structure; Quinazolinones; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2015 |
Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.
Topics: Antineoplastic Agents; Apoptosis; Benzofurans; Biocatalysis; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Design; Humans; Pyridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2017 |
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA; Humans; Indoles; Molecular Docking Simulation; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2019 |
Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis.
Topics: Amsacrine; Camptothecin; Chromosome Aberrations; Chromosomes, Human; Daunorubicin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Ellipticines; Ethidium; Etoposide; Humans; In Vitro Techniques; Lymphocytes; Mitosis; Mitoxantrone; Nalidixic Acid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1992 |
Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Topics: Adenoviruses, Human; Alkaloids; Blotting, Southern; Camptothecin; Cell Nucleus; Deoxyribonucleoproteins; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Viral; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Ellipticines; Etoposide; HeLa Cells; Humans; Microscopy, Electron; Templates, Genetic; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription, Genetic | 1990 |
Patterns of strongly protein-associated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons.
Topics: Animals; Camptothecin; Chlorocebus aethiops; Deoxyribonucleoproteins; DNA Replication; DNA, Viral; Ellipticines; Etoposide; Proflavine; Simian virus 40; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1990 |
Topoisomerase I and II activities are required for Epstein-Barr virus replication.
Topics: Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Viral; Ellipticines; Herpesvirus 4, Human; Virus Replication | 1993 |
Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases assayed in the wing spot test of Drosophila melanogaster.
Topics: Animals; Camptothecin; Drosophila melanogaster; Ellipticines; Enzyme Inhibitors; Etoposide; Female; Male; Mutagenicity Tests; Mutation; Recombination, Genetic; Teniposide; Topoisomerase I Inhibitors | 1996 |
Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents.
Topics: Adenosine Triphosphatases; Amsacrine; Antineoplastic Agents; Aphidicolin; Camptothecin; Dactinomycin; Daunorubicin; DNA; DNA Helicases; Ellipticines; Enzyme Inhibitors; Ethidium; Etoposide; Genistein; Humans; Isoflavones; Nogalamycin; Novobiocin; Topoisomerase I Inhibitors | 1997 |
Inhibition of pea chloroplast DNA helicase unwinding and ATPase activities by DNA-interacting ligands.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amsacrine; Camptothecin; Chloroplasts; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Ethidium; Etoposide; Genistein; Hydrolysis; Intercalating Agents; Ligands; Nogalamycin; Novobiocin; Pisum sativum | 1998 |
Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Survival; CHO Cells; Comet Assay; Cricetinae; DNA Damage; DNA Fragmentation; Ellipticines; Enzyme Inhibitors; Etoposide; Formazans; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan | 2002 |
Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.
Topics: Antineoplastic Agents; Biosensing Techniques; Camptothecin; Cell Line, Tumor; Checkpoint Kinase 2; Ellipticines; Genes, p53; High-Throughput Screening Assays; Humans; Imidazoles; Mitoxantrone; Piperazines; Protein Binding; Protein Interaction Mapping; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-mdm2; Recombinant Fusion Proteins; Small Molecule Libraries; Spectrometry, Fluorescence; Topotecan; Tumor Suppressor Protein p53 | 2010 |
Inhibition of unwinding and ATPase activities of pea MCM6 DNA helicase by actinomycin and nogalamycin.
Topics: Adenosine Triphosphatases; Camptothecin; Cisplatin; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Enzyme Inhibitors; Etoposide; Intercalating Agents; Mitoxantrone; Nogalamycin; Novobiocin; Pisum sativum; Plant Proteins | 2011 |